Collaboration combines Intellia’s leading CRISPR-based platform, including its DNA writing technology, with ReCode’s proprietary Selective Organ Targeting (SORT) lipid nanoparticle (LNP) to extend the ...
A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to address the longtime challenge of bringing their treatments to patients by ...
LOS ANGELES, Nov. 11, 2025 /PRNewswire/ -- After years of confidential development — and fresh off an exclusive Deadline report on Nov. 10 — TACHI AI, a pioneering AI startup founded by filmmakers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback